Ранее 2016 года (иностранная)

Logo1

Ivashchenko D, Rusin I, Sychev D, et al. The frequency of CYP2C9, VKORC1, and CYP4F2 polymorphisms in Russian patients with high thrombotic risk. Medicina (Kaunas). 2013;49(12):517-21.
Mirzaev K, Sychev D, Arutyunyan G, et al. Cytochrome 2C19 Enzyme Polymorphism Frequency in Different Indigenous Ethnic Groups in Russian Federation: A Systematic Review J Pharmacogenomics Pharmacoproteomics 2014 5:136.
Sychev DA, Malova EU. Evidence-based pharmacogenetics: Is it possible? Int J Risk Saf Med. 2015;27:97-98.
Zagorodnikova Goryachkina K, Burbello A, Sychev D, et al. Clinical pharmacology in Russia-historical development and current state. Eur J Clin Pharmacol. 2015;71(2):159-63.
Zastrozhin MS, Smirnov VV, Sychev DA, et al. CYP3A4 activity and haloperidol effects in alcohol addicts. Int J Risk Saf Med. 2015;27:23-4.
Zhestovskaja AS, Kukes VG, Sychev DA. Personalized medicine: myth or reality? The position of Russian clinical pharmacologists. EPMA J.2013;4(1):13.
Публикации членов общества на иностранном языке